Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2011

01-10-2011 | Research Article

Community pharmacists’ opinions of their role in administering non-prescription medicines in an emergency

Authors: Sara S. McMillan, H. Laetitia Hattingh, Michelle A. King

Published in: International Journal of Clinical Pharmacy | Issue 5/2011

Login to get access

Abstract

Objective To obtain community pharmacists’ opinions of their role in administering Pharmacy (S2) and Pharmacist Only (S3) Medicines in a medical emergency. These medicines can only be sold in a pharmacy and are not available for self-selection by patients. Whilst qualified pharmacy assistants can supply S2 medicines, pharmacists must be directly involved in the supply of S3 medicines. Setting Community pharmacies in South East Queensland, Australia. Method A survey of 151 Gold Coast and Toowoomba community pharmacists was conducted during October 2009. Main outcome measures Pharmacists were asked their opinions as to whether the administration of S2 and S3 medicines should fall within their scope of practice, whether they had administered S2 and S3 medicines in a medical emergency in the past and if clarification of this role was required. Results The study achieved a 30% (n = 45) response rate and demonstrated similar results regarding whether pharmacists should administer salbutamol (22/44), adrenaline (23/42), glyceryl trinitrate (22/43) and aspirin (18/36) in a medical emergency. The majority (36/43) believed that role clarification was required. Pharmacists were more likely to administer an S3 medicine in a medical emergency when they considered potential outcomes first, had no easy access to a doctor and the patient could not administer the medicine they carried with them themselves (40/45). Conclusion Community pharmacists have direct access to S2 and S3 medicines that could be required in the management of a variety of medical emergencies. This study demonstrates that some pharmacists have administered S2 and S3 medicines in an emergency situation. However, there are currently no clear guidelines for pharmacists when faced with a medical emergency other than to act within their professional competence. To promote patient safety through the appropriate use of S2 and S3 medicines in the event of a medical emergency, additional training of pharmacists on the administration of these readily accessible medicines is needed. Clarification of the role of pharmacists in an emergency situation is required.
Literature
1.
9.
go back to reference Hind C, Downie G. Vaccine administration in pharmacies–a Scottish success story. Pharm J. 2006;277:134–6. Hind C, Downie G. Vaccine administration in pharmacies–a Scottish success story. Pharm J. 2006;277:134–6.
11.
go back to reference Harrison T. What are the latest expectations for first aid and how can you meet them? Pharm J. 2010;284:455–7. Harrison T. What are the latest expectations for first aid and how can you meet them? Pharm J. 2010;284:455–7.
14.
go back to reference Low J, Hattingh L, Forrester K. Australian pharmacy law and practice. NSW: Mosby Elsevier; 2010. p. 189–200. Low J, Hattingh L, Forrester K. Australian pharmacy law and practice. NSW: Mosby Elsevier; 2010. p. 189–200.
15.
go back to reference Hattingh L, Forrester K, Smith N, Searle J. Pharmacy practice developments: the potential impact on pharmacists’ legal liability. J Law Med. 2007;14:397–402.PubMed Hattingh L, Forrester K, Smith N, Searle J. Pharmacy practice developments: the potential impact on pharmacists’ legal liability. J Law Med. 2007;14:397–402.PubMed
17.
go back to reference Pharmaceutical Society of Australia. Professional practice standards—Version 4—June 2010. 4th ed. ACT: Pharmaceutical Society of Australia; 2010. Pharmaceutical Society of Australia. Professional practice standards—Version 4—June 2010. 4th ed. ACT: Pharmaceutical Society of Australia; 2010.
20.
go back to reference Machado C, Barlows T, Marsh W, Coto-DePani Y, Dalin G. Pharmacists on the emergency cardiopulmonary resuscitation team: their responsibilities, training and attitudes. Hosp Pharm. 2003;38(1):40–9. Machado C, Barlows T, Marsh W, Coto-DePani Y, Dalin G. Pharmacists on the emergency cardiopulmonary resuscitation team: their responsibilities, training and attitudes. Hosp Pharm. 2003;38(1):40–9.
22.
go back to reference Pace A, Flowers S, Hastings J. Arkansas community pharmacists’ opinions on providing immunizations. Journal of Pharmacy Practice. 2010;23(5):496–501.PubMedCrossRef Pace A, Flowers S, Hastings J. Arkansas community pharmacists’ opinions on providing immunizations. Journal of Pharmacy Practice. 2010;23(5):496–501.PubMedCrossRef
23.
go back to reference Guild Insurance Limited. Matters of interest—Legal advice: administration of medicines in a medical emergency. Guild Insurance Ltd. August 2010. Guild Insurance Limited. Matters of interest—Legal advice: administration of medicines in a medical emergency. Guild Insurance Ltd. August 2010.
Metadata
Title
Community pharmacists’ opinions of their role in administering non-prescription medicines in an emergency
Authors
Sara S. McMillan
H. Laetitia Hattingh
Michelle A. King
Publication date
01-10-2011
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9540-z

Other articles of this Issue 5/2011

International Journal of Clinical Pharmacy 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine